Related Experiment Video
Updated: Aug 14, 2026

Microtiter Dish Biofilm Formation Assay
Published on: January 30, 2011
Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A
Daqian Sun1, M A Accavitti, J D Bryers
1Department of Chemical Engineering, University of Connecticut, Storrs, Connecticut, USA.
Abstract:
Staphylococcus epidermidis expresses a 140-kDa cell wall-bound protein accumulation-associated protein (AAP) to adhere to and accumulate as a biofilm on a surface. Potentially blocking AAP with a monoclonal antibody (MAb) could reduce or eliminate S. epidermidis bacterial colonization of biomedical devices. Here, we report on our efforts to (i) isolate AAP, (ii) generate MAbs against AAP, and (iii) determine the efficacy of MAbs to inhibit S. epidermidis biofilm formation. An M7 S. epidermidis mutant, reportedly deficient in AAP expression, was used as a negative control. Postinoculation murine sera, containing polyclonal antibodies against AAP, were able to reduce S. epidermidis biofilm formation by 54%. Select MAbs against AAP were able to reduce S. epidermidis by no more than 66%. Two MAb mixtures, 12C6/12A1 and 3C1/12A1, reduced S. epidermidis accumulation up to 79 and 87%, respectively, significantly more than individual MAbs. Contrary to a previous report, biofilm-deficient S. epidermidis mutant M7 expressed a 200-kDa protein on its cell wall that specifically bound AAP MAbs. Peptide characterization of this M7 protein by microcapillary reversed-phase high-pressure liquid chromatography-nanoelectrospray tandem mass spectrometry resulted in 53% homology with AAP. Ongoing studies will elucidate the dynamic expression of AAP and the M7 200-kDa protein in order to define their roles in biofilm formation.
Insights
Monoclonal antibodies targeting Staphylococcus epidermidis accumulation-associated protein (AAP) significantly reduced bacterial biofilm formation on surfaces. Combinations of antibodies were most effective, showing up to 87% reduction in S. epidermidis colonization.
Area of Science:
- Microbiology
- Immunology
- Biotechnology
Background:
- Staphylococcus epidermidis forms biofilms on biomedical devices, mediated by the cell wall-bound accumulation-associated protein (AAP).
- Targeting AAP with antibodies presents a potential strategy to prevent S. epidermidis colonization and biofilm formation.
Purpose of the Study:
- To isolate AAP and generate monoclonal antibodies (MAbs) against it.
- To evaluate the efficacy of these MAbs in inhibiting S. epidermidis biofilm formation.
Main Methods:
- Isolation of AAP and generation of MAbs.
- Testing polyclonal and monoclonal antibodies against S. epidermidis biofilm formation.
- Characterization of a protein from the S. epidermidis M7 mutant using mass spectrometry.
Main Results:
- Polyclonal antibodies reduced biofilm formation by 54%.
- Individual MAbs reduced biofilm formation by up to 66%.
- MAb mixtures (12C6/12A1 and 3C1/12A1) achieved 79% and 87% reduction, respectively.
- The S. epidermidis M7 mutant expressed a 200-kDa protein with 53% homology to AAP.
Conclusions:
- Monoclonal antibodies, particularly in combination, are effective in inhibiting S. epidermidis biofilm formation.
- The M7 mutant's 200-kDa protein warrants further investigation for its role in biofilm development.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

